
                                SEQUENCE LISTING

<110> Merck & Co., Inc.
      Savage, Mary J.
      Kinney, Gene G.
      Liang, Xiaoping
      Citron, Michael
      Rosen, Laura B.

<120> VACCINE FOR THE TREATMENT OF ALZHEIMER'S
  DISEASE

<130> MRL-NOP-00017

<150> 61/134,224          
<151> 2008-07-08  

<160> 12

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 1
Glu Phe Arg His Asp Ser Gly Tyr
 1               5              


<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 2
Ala Glu Asp Val Gly Ser Asn Lys
 1               5              


<210> 3
<211> 42
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 3
Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys
 1               5                  10                  15      
Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile
            20                  25                  30          
Gly Leu Met Val Gly Gly Val Val Ile Ala
        35                  40          


<210> 4
<211> 41
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 4
Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu
 1               5                  10                  15      
Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly
            20                  25                  30          
Leu Met Val Gly Gly Val Val Ile Ala
        35                  40      


<210> 5
<211> 40
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<221> VARIANT        
<222> 1
<223> Xaa = modified amino acid

<400> 5
Xaa Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val
 1               5                  10                  15      
Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu
            20                  25                  30          
Met Val Gly Gly Val Val Ile Ala
        35                  40  


<210> 6
<211> 39
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 6
Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe
 1               5                  10                  15      
Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met
            20                  25                  30          
Val Gly Gly Val Val Ile Ala
        35                  


<210> 7
<211> 38
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 7
Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe
 1               5                  10                  15      
Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val
            20                  25                  30          
Gly Gly Val Val Ile Ala
        35              


<210> 8
<211> 37
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 8
His Asp Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe Ala
 1               5                  10                  15      
Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly
            20                  25                  30          
Gly Val Val Ile Ala
        35          


<210> 9
<211> 35
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 9
Ser Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp
 1               5                  10                  15      
Val Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly Gly Val
            20                  25                  30          
Val Ile Ala
        35  


<210> 10
<211> 34
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 10
Gly Tyr Glu Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val
 1               5                  10                  15      
Gly Ser Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly Gly Val Val
            20                  25                  30          
Ile Ala
        


<210> 11
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<221> VARIANT        
<222> 1
<223> Xaa = modified amino acid

<400> 11
Xaa Val His His Gln Lys Leu Val Phe Phe Ala Glu Asp Val Gly Ser
 1               5                  10                  15      
Asn Lys Gly Ala Ile Ile Gly Leu Met Val Gly Gly Val Val Ile Ala
            20                  25                  30          


<210> 12
<211> 26
<212> PRT
<213> Artificial Sequence

<220> 
<223> sequence is synthesized

<400> 12
Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile
 1               5                  10                  15      
Gly Leu Met Val Gly Gly Val Val Ile Ala
            20                  25      

